Nanjing Leads Biolabs Enrolls First Patient in LBL-024 Cancer Trial
Nanjing Leads Biolabs enrolled the first patient in a Phase Ib/II trial of LBL-024 for metastatic colorectal cancer.
Nanjing Leads Biolabs enrolled the first patient in a Phase Ib/II trial of LBL-024 for metastatic colorectal cancer.